Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (atsiveria naujas langas)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Šaltinis‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Kodas‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (atsiveria naujas langas)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (atsiveria naujas langas)

Banan M.

Šaltinis‎: Ann Hematol 2013;92(3):289-99.

Kodas‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (atsiveria naujas langas)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (atsiveria naujas langas)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Šaltinis‎: Transfusion 2007;47(10):1830-6.

Kodas‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (atsiveria naujas langas)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (atsiveria naujas langas)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Šaltinis‎: Blood 1996;87(3):887-92.

Kodas‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (atsiveria naujas langas)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (atsiveria naujas langas)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Šaltinis‎: Iran J Blood Cancer 2009;1(4):147-50.

Kodas‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (atsiveria naujas langas)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (atsiveria naujas langas)

Karimi M, Cohan N, Pishdad P.

Šaltinis‎: Hematology 2015;20(1):53-7.

Kodas‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (atsiveria naujas langas)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (atsiveria naujas langas)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Šaltinis‎: Int J Hematol 2012;95(1):51-6.

Kodas‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (atsiveria naujas langas)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (atsiveria naujas langas)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Šaltinis‎: Hemoglobin 2014;38(2):115-8.

Kodas‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (atsiveria naujas langas)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (atsiveria naujas langas)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Šaltinis‎: Blood 2013;121(12):2199-212.

Kodas‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (atsiveria naujas langas)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (atsiveria naujas langas)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Šaltinis‎: Sci Rep. 2022;12(1):2752.

Kodas‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (atsiveria naujas langas)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (atsiveria naujas langas)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Šaltinis‎: Haematologica 2004;89(10):1172-8.

Kodas‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (atsiveria naujas langas)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (atsiveria naujas langas)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Šaltinis‎: Arch Iran Med 2009;12(3):295-7.

Kodas‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (atsiveria naujas langas)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (atsiveria naujas langas)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Šaltinis‎: Eur J Haematol 1996;56(5):326-8.

Kodas‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (atsiveria naujas langas)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (atsiveria naujas langas)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Šaltinis‎: J Matern Fetal Med 1999;8(1):1-7.

Kodas‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (atsiveria naujas langas)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (atsiveria naujas langas)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Šaltinis‎: Acta Haematol 2004;111(4):189-95.

Kodas‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (atsiveria naujas langas)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (atsiveria naujas langas)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Šaltinis‎: Ann Hematol 2001;80(8):492-5.

Kodas‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (atsiveria naujas langas)

Fetal globin induction--can it cure beta thalassemia? (atsiveria naujas langas)

Perrine SP.

Šaltinis‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Kodas‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (atsiveria naujas langas)